The necrosis-inducing toxin of Mycobacterium tuberculosis
结核分枝杆菌的坏死诱导毒素
基本信息
- 批准号:9178625
- 负责人:
- 金额:$ 53.42万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-12-01 至 2020-11-30
- 项目状态:已结题
- 来源:
- 关键词:AntitoxinsBacterial InfectionsBacterial ToxinsBindingBinding SitesBiological AssayC-terminalCell DeathCellsCessation of lifeComplexContainmentCrystallizationCytosolELF3 geneEscherichia coliEventGlycoside HydrolasesHumanImmunityInfectionKineticsLinkMembraneMembrane ProteinsMolecularMutagenesisMycobacterium tuberculosisNAD+ NucleosidaseNamesNecrosisOperonPathogenesisPathway interactionsPeptide HydrolasesPlayProtein SecretionProteinsRoleStructureSystemToxic effectToxinTuberculosisVirulenceVirulence Factorsadaptive immune responseanalogcytotoxicityenzyme activityexperimental studygenetic selectionglobal healthkillingsmacrophagemembermutantnovelpathogenpublic health relevance
项目摘要
DESCRIPTION (provided by applicant): Tuberculosis (TB) is one of the most important and widespread bacterial diseases and a global health threat. Survival within infected macrophages is a key feature of Mycobacterium tuberculosis (Mtb) pathogenesis and is crucial to a persistent infection in the human host. The lack of any protein with sequence similarities to bacterial toxins
and the apparent absence of a protein toxin with profound effects on host cells led to the widely accepted assumption that Mtb does not have these classical virulence factors. However, this paradigm was challenged by our discovery of the outer membrane protein CpnT which is utilized by Mtb to secrete a toxic C- terminal domain. This toxin is required by Mtb to replicate i macrophages, is the major cytotoxicity factor of Mtb in macrophages and causes necrotic cell death of host cells. Hence, we named this protein Tuberculosis Necrotizing Toxin (TNT). Killing of infected macrophages by necrosis is a well-known, but poorly understood virulence mechanism of Mtb to escape phagosomal containment and the adaptive immune response. Recently, we discovered that TNT is a novel NAD+-glycohydrolase which gains access to the cytosol of infected macrophages in an ESX-1 dependent manner. Mtb protects itself from CpnT/TNT toxicity by producing an antitoxin which we named Immunity Factor of TNT (IFT). IFT inactivates the enzyme activity of TNT upon binding. The discovery of IFT enabled us to produce TNT protein in mg quantities and, subsequently, to solve the crystal structure of the TNT-IFT complex and characterize the purified TNT protein enzymatically. We have identified catalytically inactive TNT mutants, which we will use to define the role of this Mtb toxin in the molecular pathway ultimately leading to necrosis of infected macrophages. Thus, we are now able to examine a novel molecular mechanism of paramount importance for the interaction of Mtb with host cells. These findings will also be important for more than 200 bacterial and fungal pathogens with TNT homologs and for understanding the molecular consequences of NAD+ depletion in host cells.
描述(申请人提供):结核病(TB)是最重要和最广泛的细菌性疾病之一,是全球性的健康威胁。在感染的巨噬细胞内存活是结核分枝杆菌(Mtb)发病机制的关键特征,并且对于人类宿主中的持续感染至关重要。缺乏任何与细菌毒素序列相似的蛋白质
并且明显缺乏对宿主细胞具有深远影响的蛋白质毒素导致了广泛接受的假设,即Mtb不具有这些经典的毒力因子。然而,我们发现外膜蛋白CpnT挑战了这种范例,外膜蛋白CpnT被Mtb用来分泌毒性C末端结构域。该毒素是Mtb在巨噬细胞中复制所需的,是Mtb在巨噬细胞中的主要细胞毒性因子,并引起宿主细胞的坏死性细胞死亡。因此,我们将这种蛋白质命名为结核坏死毒素(TNT)。通过坏死杀死受感染的巨噬细胞是Mtb逃避吞噬体遏制和适应性免疫应答的众所周知但知之甚少的毒力机制。最近,我们发现TNT是一种新的NAD+-糖水解酶,它以ESX-1依赖的方式进入感染的巨噬细胞的胞质溶胶。结核分枝杆菌通过产生抗毒素保护自身免受CpnT/TNT毒性,我们将其命名为TNT免疫因子(IFT)。IFT在结合时使TNT的酶活性失活。IFT的发现使我们能够以mg的量生产TNT蛋白,随后,解决了TNT-IFT复合物的晶体结构,并对纯化的TNT蛋白进行了酶促表征。我们已经确定了无催化活性的TNT突变体,我们将使用这些突变体来确定这种Mtb毒素在最终导致受感染的巨噬细胞坏死的分子途径中的作用。因此,我们现在能够检查一个新的分子机制的Mtb与宿主细胞的相互作用至关重要。这些发现对于200多种具有TNT同源物的细菌和真菌病原体以及理解宿主细胞中NAD+耗尽的分子后果也很重要。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MICHAEL NIEDERWEIS其他文献
MICHAEL NIEDERWEIS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MICHAEL NIEDERWEIS', 18)}}的其他基金
Toxin secretion and trafficking by Mycobacterium tuberculosis
结核分枝杆菌的毒素分泌和运输
- 批准号:
10632980 - 财政年份:2023
- 资助金额:
$ 53.42万 - 项目类别:
Siderophore secretion by Mycobacterium tuberculosis
结核分枝杆菌分泌铁载体
- 批准号:
10379326 - 财政年份:2021
- 资助金额:
$ 53.42万 - 项目类别:
Siderophore-dependent inhibitors of Mycobacterium tuberculosis
结核分枝杆菌铁载体依赖性抑制剂
- 批准号:
10199992 - 财政年份:2020
- 资助金额:
$ 53.42万 - 项目类别:
Siderophore-dependent inhibitors of Mycobacterium tuberculosis
结核分枝杆菌铁载体依赖性抑制剂
- 批准号:
10041925 - 财政年份:2020
- 资助金额:
$ 53.42万 - 项目类别:
Heme and hemoglobin utilization by Mycobacterium tuberculosis
结核分枝杆菌利用血红素和血红蛋白
- 批准号:
10320404 - 财政年份:2019
- 资助金额:
$ 53.42万 - 项目类别:
Single-chain MspA for nanopore sequencing of DNA
用于 DNA 纳米孔测序的单链 MspA
- 批准号:
9918943 - 财政年份:2019
- 资助金额:
$ 53.42万 - 项目类别:
Heme and hemoglobin utilization by Mycobacterium tuberculosis
结核分枝杆菌利用血红素和血红蛋白
- 批准号:
10082420 - 财政年份:2019
- 资助金额:
$ 53.42万 - 项目类别:
Heme and hemoglobin utilization by Mycobacterium tuberculosis
结核分枝杆菌利用血红素和血红蛋白
- 批准号:
10535449 - 财政年份:2019
- 资助金额:
$ 53.42万 - 项目类别:
相似海外基金
New roles of IFN-inducible OAS proteins in innate immune defense against bacterial infections
IFN诱导的OAS蛋白在针对细菌感染的先天免疫防御中的新作用
- 批准号:
10649771 - 财政年份:2023
- 资助金额:
$ 53.42万 - 项目类别:
Derivation and validation of a clinical prediction rule to identify febrile infants 61 to 90 days old at low and non-negligible risk of invasive bacterial infections
推导和验证临床预测规则,以识别 61 至 90 天大的发热婴儿,其侵袭性细菌感染的风险较低且不可忽略
- 批准号:
10574286 - 财政年份:2023
- 资助金额:
$ 53.42万 - 项目类别:
Structural and functional studies of YbtPQ for fighting bacterial infections
YbtPQ 对抗细菌感染的结构和功能研究
- 批准号:
10644889 - 财政年份:2023
- 资助金额:
$ 53.42万 - 项目类别:
A gut feeling: How can gastrointestinal bacterial infections alter female reproductive tract immunity and control of sexually transmitted infections
直觉:胃肠道细菌感染如何改变女性生殖道免疫力和性传播感染的控制
- 批准号:
MR/X031993/1 - 财政年份:2023
- 资助金额:
$ 53.42万 - 项目类别:
Research Grant
Molecular probes to diagnose pathoadapatations in bacterial infections
诊断细菌感染病理适应的分子探针
- 批准号:
EP/X014479/1 - 财政年份:2023
- 资助金额:
$ 53.42万 - 项目类别:
Research Grant
Using Small Area Variation Analysis to Investigate Sources of Practice Variation for Febrile Infants at Risk for Invasive Bacterial Infections
使用小面积变异分析来调查有侵袭性细菌感染风险的发热婴儿的实践变异来源
- 批准号:
10588846 - 财政年份:2023
- 资助金额:
$ 53.42万 - 项目类别:
Host Directed Orynotide for MDR Gram Negative Bacterial Infections
宿主定向 Orynotide 用于治疗耐多药革兰氏阴性细菌感染
- 批准号:
10674221 - 财政年份:2023
- 资助金额:
$ 53.42万 - 项目类别:
SimCell vaccines against Staphylococcus aureus bacterial infections
针对金黄色葡萄球菌细菌感染的 SimCell 疫苗
- 批准号:
10073241 - 财政年份:2023
- 资助金额:
$ 53.42万 - 项目类别:
Grant for R&D
I-Corps: Mitigating Multidrug Resistant Bacterial Infections with Biocompatible and Environmentally Benign Nanoantibiotics
I-Corps:利用生物相容性且对环境无害的纳米抗生素减轻多重耐药细菌感染
- 批准号:
2306943 - 财政年份:2023
- 资助金额:
$ 53.42万 - 项目类别:
Standard Grant
Multidimensional development of high-affinity anti-glycan antibodies to fight deadly bacterial infections
多维开发高亲和力抗聚糖抗体以对抗致命细菌感染
- 批准号:
10549640 - 财政年份:2023
- 资助金额:
$ 53.42万 - 项目类别: